Ashe Andrew D. Insider Trades

Insider Trading History

Track insider trading activity for Ashe Andrew D.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Verve Therapeutics
Verve Therapeutics VERV
See Remarks
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$3.66M 348,828 shares
$10.50
$11.13
Verve Therapeutics
Verve Therapeutics VERV
See Remarks
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.38M 663,274 shares
$11.13
$11.13
Verve Therapeutics
Verve Therapeutics VERV
See Remarks
Holding Value $3.88M 348,828 shares
Last Trade
Apr 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.1k 2,681 shares
$4.15
$11.13
Verve Therapeutics
Verve Therapeutics VERV
See Remarks
Holding Value $3.91M 351,509 shares
Last Trade
Apr 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$37.2k 9,000 shares
$4.14
$11.13
Verve Therapeutics
Verve Therapeutics VERV
See Remarks
Holding Value $301k 27,000 shares
Last Trade
Apr 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$37.2k 9,000 shares
$4.14
$11.13
Verve Therapeutics
Verve Therapeutics VERV
See Remarks
Holding Value $2.5M 225,000 shares
Last Trade
Jan 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.35M 225,000 shares
$6.01
$11.13
Verve Therapeutics
Verve Therapeutics VERV
See Remarks
Holding Value $3.81M 342,509 shares
Last Trade
May 14, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$476k 76,000 shares
$6.26
$11.13
Verve Therapeutics
Verve Therapeutics VERV
See Remarks
Holding Value $1.67M 150,000 shares
Last Trade
Feb 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.91M 150,000 shares
$12.75
$11.13
Verve Therapeutics
Verve Therapeutics VERV
See Remarks
Holding Value $2.03M 182,800 shares
Last Trade
Feb 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.98M 182,800 shares
$21.76
$11.13
Verve Therapeutics
Verve Therapeutics VERV
See Remarks
Holding Value $0 0 shares
Last Trade
Aug 25, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.12M 51,203 shares
$41.31
$11.13
Verve Therapeutics
Verve Therapeutics VERV
See Remarks
Holding Value $1.39M 125,000 shares
Last Trade
Feb 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.87M 125,000 shares
$30.94
$11.13
Verve Therapeutics
Verve Therapeutics VERV
See Remarks
Holding Value $1.9M 170,722 shares
Last Trade
Dec 02, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$128k 4,000 shares
$32.10
$11.13
Verve Therapeutics
Verve Therapeutics VERV
See Remarks
Holding Value $240k 21,599 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$689k 21,599 shares
$31.92
$11.13
Verve Therapeutics
Verve Therapeutics VERV
See Remarks
Holding Value $1.86M 166,722 shares
Last Trade
Jun 16, 2021 Sale
No data
No data
$11.13
Applied Genetic Technologies
Applied Genetic Technologies AGTC
General Counsel
Holding Value $39.4k 100,000 shares
Last Trade
Aug 01, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$460k 100,000 shares
$4.60
$0.39

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up